Skip to main content
SpringerLink
Log in

High-dose lisinopril dominates low dose in ATLAS patients

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

High-dose lisinopril dominates low dose in ATLAS patients. Pharmacoecon. Outcomes News 302, 7 (2001). https://doi.org/10.1007/BF03280191

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03280191

Keywords

Search

Navigation